Piper Sandler Maintains Overweight on DexCom, Raises Price Target to $88
Benzinga Newsdesk 4 months ago
NewsPrice TargetAnalyst Ratings
Piper Sandler analyst Matt O'Brien maintains DexCom (NASDAQ:DXCM) with a Overweight and raises the price target from $75 to $88.
Piper Sandler analyst Matt O'Brien maintains DexCom (NASDAQ:DXCM) with a Overweight and raises the price target from $75 to $88.